시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 감기 및 인플루엔자 보충제 시장 보고서(2025년)
Cold And Flu Supplements Global Market Report 2025
상품코드 : 1750944
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

감기 및 인플루엔자 보충제 시장 규모는 향후 수 년간 급성장할 것으로 예측됩니다. 식품에 대한 수요 증가, 영양 보충제의 장점에 대한 의식 증가, 천연 및 식물 기반 허브 추출물에 대한 선호도 증가로 인한 것입니다.

계절성 질환의 이환율 증가는 향후 몇 년간의 감기 및 인플루엔자 보충제 시장의 성장을 뒷받침할 것으로 예측됩니다. 추가하는 것은 기온과 습도의 패턴을 방해하여 감염 시즌을 연장하고, 인플루엔자 등의 바이러스의 확산을 촉진하는 기후 변화가 주요 원인입니다. 그리고 계절성 질환의 관리에 공헌합니다. 미국 정부기관인 노동통계국은 민간기업 직원 1만명당 이환율이 2021년 37.7명에서 2022년에는 45.2명으로 상승했다고 밝혔습니다.

감기 및 인플루엔자 보충제 시장의 선두 기업은 한 번 복용으로 종합적인 증상 완화를 제공하고 소비자의 편의성과 효능을 모두 향상시키는 올인원형 다증후 치료제 등의 제품으로 혁신을 도모하고 있습니다. 제제는 코 막힘, 기침, 발열, 신체 통증 등 다양한 감기와 인플루엔자의 증상을 동시에 완화하도록 설계되어 있으며, 종합적인 해결책을 제공합니다. Reckitt Benckiser Group plc는 아침 감기와 독감 증상을 신속하게 완화하는 것을 목표로 한 신제품, Fast-Max Kickstart를 발매했습니다. 이 제품은 코 막힘, 인후통, 몸의 통증을 효과적으로 완화시키는 속효성이 있는 성분을 배합하고 있어 소비자가 하루를 쾌적하게 스타트할 수 있도록 서포트합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 태와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Cold and flu supplements are dietary products designed to support the immune system and help relieve symptoms associated with colds and the flu. They are commonly used to boost immunity, reduce congestion, soothe sore throats, and aid in overall recovery.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

These supplements primarily include vitamins and minerals, herbal extracts, and natural molecules. Vitamins and minerals are vital nutrients that contribute to key bodily functions such as immune support, energy production, and cell repair. They are available in various forms, including tablets and capsules, powders, syrups, and others, and are distributed through multiple channels such as pharmacies and drug stores, hypermarkets and supermarkets, online platforms, and other outlets.

The cold and flu supplements market research report is one of a series of new reports from The Business Research Company that provides cold and flu supplements market statistics, including the cold and flu supplements industry global market size, regional shares, competitors with the cold and flu supplements market share, detailed cold and flu supplements market segments, market trends, and opportunities, and any further data you may need to thrive in the cold and flu supplements industry. These cold and flu supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cold and flu supplements market size has grown rapidly in recent years. It will grow from$19.98 billion in 2024 to $22.63 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth during the historic period can be attributed to an increasing aging population, a rise in flu cases, enhanced government support, growing consumer purchasing power, and increased spending on products that boost immune health.

The cold and flu supplements market size is expected to see rapid growth in the next few years. It will grow to$36.82 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth anticipated in the forecast period can be attributed to the rising incidence of respiratory infections, an increasing burden of seasonal influenza, growing demand for immune support supplements, heightened awareness of the benefits of dietary supplements, and a rising preference for natural and plant-based herbal extracts. Key trends expected during this period include innovative product formulations, the emergence of personalized medicine, development of targeted solutions, and advances in nutritional sciences.

The increasing incidence of seasonal diseases is expected to boost the growth of the cold and flu supplements market in the coming years. Seasonal diseases are ailments that occur more frequently during specific times of the year, often influenced by changes in weather, climate, or environmental conditions. The rising occurrence of these illnesses is largely attributed to climate change, which disrupts temperature and humidity patterns, thereby extending transmission seasons and facilitating the spread of viruses such as influenza. Cold and flu supplements contribute to managing seasonal illnesses by boosting immunity, minimizing symptom severity, and promoting quicker recovery. For example, in January 2025, the Nippon Communications Foundation, a Japan-based non-profit organization, reported that influenza cases in Japan surged to a record 317,812 in December 2024. Additionally, in November 2023, the Bureau of Labor Statistics, a US-based government agency, noted that the illness rate among private industry employees rose to 45.2 cases per 10,000 full-time equivalent workers in 2022, up from 37.7 cases in 2021. As a result, the growing frequency of seasonal diseases is fueling demand for cold and flu supplements.

Leading players in the cold and flu supplements market are innovating with products such as all-in-one multi-symptom remedies to provide comprehensive symptom relief in a single dose, improving both convenience and efficacy for consumers. These all-in-one formulations are designed to simultaneously alleviate various cold and flu symptoms-including congestion, cough, fever, and body aches-offering a holistic solution. For instance, in January 2024, Reckitt Benckiser Group plc, a UK-based health, hygiene, and nutrition company, launched Fast-Max Kickstart, a new product aimed at delivering fast relief for morning cold and flu symptoms. The formulation features rapid-acting ingredients that effectively ease congestion, sore throat, and body aches, helping consumers start their day more comfortably. Its distinct cooling sensation also offers a refreshing effect while soothing irritation.

In September 2023, Sanofi S.A., a France-based pharmaceutical firm, acquired Qunol LLC for $1.4 billion. This acquisition is part of Sanofi's strategy to enhance its consumer healthcare portfolio by increasing its footprint in the wellness and dietary supplements sector. By integrating Qunol's widely recognized brand-particularly known for products supporting heart health and immune function-Sanofi aims to capitalize on growing demand for preventive health solutions, including those that assist in managing cold and flu symptoms. Qunol LLC is a US-based producer of immune support supplements geared toward reducing the impact of cold and flu ailments.

Major players in the cold and flu supplements market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi SA, Reckitt Benckiser Group plc, Haleon plc, Perrigo Company plc, Amway Corporation, Nu Skin Enterprises Inc., The Vitamin Shoppe Inc., NOW Health Group Inc., Nature's Sunshine Products Inc., Nature's Way Products LLC, Nordic Naturals Inc., Orthomol GmbH, Weefsel Pharma Pvt. Ltd., AdvaCare Pharma USA, Zarbee's Naturals LLC, and Neurobiologix Inc.

North America was the largest region in the cold and flu supplements market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cold and flu supplements report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cold and flu supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold and flu supplements market consists of sales of effervescent tablets, lozenges, herbal teas, and nasal sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold And Flu Supplements Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cold and flu supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cold and flu supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold and flu supplements market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cold And Flu Supplements Market Characteristics

3. Cold And Flu Supplements Market Trends And Strategies

4. Cold And Flu Supplements Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cold And Flu Supplements Growth Analysis And Strategic Analysis Framework

6. Cold And Flu Supplements Market Segmentation

7. Cold And Flu Supplements Market Regional And Country Analysis

8. Asia-Pacific Cold And Flu Supplements Market

9. China Cold And Flu Supplements Market

10. India Cold And Flu Supplements Market

11. Japan Cold And Flu Supplements Market

12. Australia Cold And Flu Supplements Market

13. Indonesia Cold And Flu Supplements Market

14. South Korea Cold And Flu Supplements Market

15. Western Europe Cold And Flu Supplements Market

16. UK Cold And Flu Supplements Market

17. Germany Cold And Flu Supplements Market

18. France Cold And Flu Supplements Market

19. Italy Cold And Flu Supplements Market

20. Spain Cold And Flu Supplements Market

21. Eastern Europe Cold And Flu Supplements Market

22. Russia Cold And Flu Supplements Market

23. North America Cold And Flu Supplements Market

24. USA Cold And Flu Supplements Market

25. Canada Cold And Flu Supplements Market

26. South America Cold And Flu Supplements Market

27. Brazil Cold And Flu Supplements Market

28. Middle East Cold And Flu Supplements Market

29. Africa Cold And Flu Supplements Market

30. Cold And Flu Supplements Market Competitive Landscape And Company Profiles

31. Cold And Flu Supplements Market Other Major And Innovative Companies

32. Global Cold And Flu Supplements Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cold And Flu Supplements Market

34. Recent Developments In The Cold And Flu Supplements Market

35. Cold And Flu Supplements Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기